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By using duplex surveillance, we demonstrated
that vein grafts performed for popliteal artery
aneurysms, as opposed to those performed for
occlusive disease, increase their diameter with time.1
In a linear regression model, the initial vein graft
diameter was predictive of diameter at final follow-
up. These data suggested that altered remodeling of
vein grafts performed in patients with peripheral
arterial aneurysms might have a beneficial effect on
patency rates.
Loftus et al2 confirmed this observation by mon-
itoring a group of infrainguinal vein grafts per-
formed from 1990 to 1995, defining aneurysm as a
focal increase of 1.5 cm or greater. Excluding all
false aneurysms, they demonstrated a 42% incidence
of vein graft aneurysm formation in patients under-
going vein grafting for popliteal artery aneurysm. In
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contrast, vein grafts performed for occlusive disease
had only a 2% incidence of aneurysm formation.
Loftus suggested that this provided evidence that
aneurysm disease is a generalized process affecting
transplanted veins and native arteries.
Fillinger et al3 demonstrated that autogenous
lower-extremity bypass grafts in patients with 
atherosclerotic occlusive disease, in contrast to
patients with aneurysmal disease, adapt to alter var-
ious physical forces, including sheer stress, by nor-
malizing their diameter with time. This study sug-
gested that saphenous vein bypass grafts performed
for occlusive disease remodel in an attempt to nor-
malize certain flow characteristics. These vein grafts
change their diameter, volume flow rate, and peak
systolic velocity and normalize their sheer stress to
approximately 20 dyne/cm2.
We sought to determine whether infrainguinal
vein reconstructions performed in patients who had
undergone prior abdominal aortic aneurysm (AAA)
repair might have superior graft patency, compared
with those in patients who had undergone prior aor-
tobifemoral bypass grafting (ABF) reconstructions
for aortoiliac occlusive disease. We also evaluated
bypass graft origin, native arterial diameter, and vein
graft diameter over time to determine whether any
of these parameters might contribute to altered vein
graft patency.
METHODS
From January 1, 1979, through December 31,
1998, 54 patients underwent infrainguinal single-
segment saphenous vein reconstructions (IRs) after
infrarenal aortic procedures. Of the 64 vein recon-
structions performed, 30 (46.9%) followed AAA
repair (AAA group) and 34 (53.1%) followed ABF
reconstructions (ABF group) for occlusive disease
only. None of the IRs performed in the AAA or ABF
groups were for femoral or popliteal artery
aneurysms. During this 20-year period, 963 patients
underwent infrarenal AAA repairs and 310 patients
underwent ABF reconstructions. During a similar
period (January 1979–December 1997), 1642 total
lower-extremity vein bypass grafting procedures
(LEB) were performed for atherosclerotic occlusive
disease in 1274 patients at the Brigham and
Women’s Hospital; these patients served as a control
group. Patients undergoing IR for femoral or
popliteal aneurysm were not included in the LEB
group. In addition, no one in the control group
(LEB) had a previous AAA or ABF repair.
In a subset of the AAA group (n = 6) and ABF
group (n = 11), in which measurement was techni-
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cally feasible with a calibrated ruler and a measured
table height, preoperative angiograms performed
before IR were retrospectively reviewed in an
attempt to compare inflow and outflow arterial
diameters. Diameter was determined at serial loca-
tions from the common femoral artery (CFA) to the
tibial vessels in a standard fashion. The CFA was
measured at the superior margin of the femoral
head. Profunda (PFA) and superficial femoral artery
(SFA) diameters were measured 1 cm distal to their
respective origins. The diameter of the popliteal
artery (POP) was measured at the level of the knee
joint. Distal runoff, including that from the anterior
tibial (AT), posterior tibial (PT), and peroneal
(PER) arteries, was measured 1 cm distal to their
origin. Measurements were determined in millime-
ters and calibrated on the bypass graft side with a
radiopaque ruler placed between the patient’s legs at
the time of imaging. A calibrated ruler and knowl-
edge of the height of the table during the angiogram
Fig 1. Life-table analysis of primary (A) and primary
revised (B) patency in abdominal aortic aneurysm (AAA),
lower-extremity bypass grafting (LEB), and aorto-
bifemoral bypass grafting (ABF) groups. *P < .001, com-
pared with the LEB and ABF groups over 60 months. **P
< .05, compared to LEB group.
A
B
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allowed for accurate, reproducible measurements of
vessel diameter. Occluded vessels were omitted from
this analysis. In IRs originating off an ABF graft, 
the CFA measurement was omitted. Data was 
compared using linear regression (X T-REG, Stata
Corporation, College Station, Tex).
In a separate subset of patients (n = 6 grafts in
AAA group; n = 6 grafts in ABF group), serial duplex
ultrasound scans were used as a means of examining
autogenous vein graft diameters over time in infrain-
guinal bypass grafts. All graft scans were performed in
an accredited vascular laboratory by registered vascu-
lar technicians. All graft scans were reviewed and read
by a single attending physician (M. D. G-H.). Serial
ultrasound scans (two per graft) were performed, with
the initial surveillance ultrasound occurring within 3
months after graft insertion. The period from the ini-
tial to the final follow-up ultrasound scanning exami-
nations ranged from 8 months to 3 years. Diameter
was determined in the same location on each graft,
just distal to the adductor canal. Individual graft
diameters were determined by using calipers (D1),
with 1 cm on the ultrasound calibration scale mea-
sured with calipers (D2). The diameter of the vein
graft bypass measured in millimeters was subsequent-
ly determined to be D1/D2 × 10. Data were com-
pared by means of a paired Student t test.
Demographics, indications for surgery, proximal
and distal anastomotic sites, distal runoff, and ori-
entation of vein grafts were recorded in a prospec-
tive fashion in the vascular registry and reviewed in
a retrospective manner. The number of distal
below-the-knee runoff vessels (0-3) was determined
after a review of each patient’s lower-extremity
angiogram. Vessels (anterior tibial, posterior tibial,
peroneal) were counted as runoff when they were
patent at the ankle. Results are reported as the mean
plus or minus the standard error of the mean.
Noncategorical variables were compared with a
Fisher exact t test. Graft patency and limb survival
were determined by means of an actuarial life table
analysis. Statistical comparison between life table
curves for primary patency, primary revised patency,
and limb salvage were made with the Mantel-Cox
rank test of significance.
RESULTS
The mean follow-up period was 32.1, 27.1, and
32.2 months in the AAA, ABF, and LEB groups,
respectively. Of the 64 IRs in the AAA and ABF
groups, 51 (80%) were primary procedures and 13
(20%) were secondary procedures. In the AAA
Table I. Demographics of AAA, ABF, and LEB groups
Risk factor AAA group N (%) ABF group N (%) LEB group N (%)
Mean age (y) 70.4* 60.4 67.1*
Sex (male:female) 23:7 (77) 21:13 (62) 979:662 (60)
Diabetes mellitus 6 (20)† 13 (38) 683 (42)
Smoking 19 (63) 23 (67) 818 (50)
Hypertension 22 (73) 25 (74) 973 (59)
Coronary artery disease 17 (57) 20 (59) 778 (47)
Cerebrovascular disease 3 (10) 1 (3) 148 (9)
COPD 13 (43)†‡ 2 (6) 222 (14)
Chronic renal failure 4 (13)‡ 0 (0) 176 (11)‡
CHF 3 (10)‡ 0 (0) NR
*P < .001, compared with ABF group.
†P < .05, compared with LEB group.
‡P < .05, compared with ABF group.
COPD, Chronic obstructive pulmonary disease; CHF, congestive heart failure; AF, atrial fibrillation; NR, not reported.
Table II. Indications for bypass grafting surgery
Indication AAA group N (%) ABF group N (%) LEB group N (%)
Claudication 8 (27) 12 (35) 423 (26)
Limb salvage 22 (73) 22 (65) 1219 (74)
Rest pain 14 (47) 16 (47) 549 (33)
Ulceration 3 (10) 5 (15) 435 (27)
Gangrene 5 (17) 1 (3) 235 (14)
group (n = 30), 26 IRs (87%) were primary proce-
dures. Of the 34 IRs in the ABF group, 25 (74%)
were primary procedures, whereas 79% of the IRs in
the LEB group were primary procedures. No statis-
tical differences existed in the number of primary or
secondary procedures performed in any of the three
groups. In the AAA group, there were 14 aortic
tube grafts, 6 aortobiiliac bypass grafts, and 10 aor-
tobifemoral bypass grafts.
The results demonstrate that although the mem-
bers of the AAA and LEB groups were older and had
more comorbidities, the members of the three
groups were similar in sex, indication for operation,
site of proximal and distal anastomosis, and number
of distal runoff vessels. The AAA group, with a mean
age of 70.4 years, and the LEB group, with a mean
age of 67.1 years, were significantly (P < .001) older
than the members of the ABF group (mean age,
60.4 years). The AAA group includes fewer patients
with diabetes mellitus than either the ABF or LEB
groups (Table I).
Limb salvage was the primary indication for IR
in all groups studied (Table II). The AAA and the
ABF groups contained only continuous segment
saphenous veins, with the vein placed in the nonre-
versed orientation in 70% and 65% of cases, respec-
tively (P = not significant). The site of both proximal
and distal anastomosis for the bypass grafts did not
vary significantly (Table III). A larger number of
patients in the ABF group (79%) had femoral-to-
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Fig 2. Cumulative 5-year limb primary patency in the
abdominal aortic aneurysm (AAA) and the aorto-
bifemoral bypass grafting (ABF) groups by origin (native
or prosthetic) of infrainguinal reconstruction. *P < .05,
compared with ABF group. **P < .007, compared with
ABF group.
Fig 3. Mean arterial diameter by angiography in the
abdominal aortic aneurysm (AAA) and the aorto-
bifemoral bypass (ABF) groups. A significant difference in
arterial diameter by disease (AAA vs ABF, *P = .001) and
by vessel (proximal—CFA, SFA, and PFA vs distal—Pop,
AT, PT, Per, +P = 0.001) exists.
Table III. Site of proximal and distal anastomoses for bypass grafts
Site AAA group N (%) ABF group N (%) LEB group N (%)
Proximal
Common femoral (artery and prosthetic) 19 (63) 27 (80) 1144 (70)
Superficial femoral 8 (27) 5 (15) 307 (19)
Profunda femoral 0 (0) 1 (3) 0 (0)
Popliteal 3 (10) 1 (3) 149 (9)
Other 0 (0) 0 (0) 42 (3)
Distal
Popliteal 15 (50) 27 (79) 783 (48)*
Above-knee 4 (13) 12 (35) 299 (18)
Below-knee 11 (37) 15 (44) 484 (30)
Tibial (including dorsalis pedis) 15 (50) 7 (21) 859 (52)*
*P < .001, compared with ABF group.
popliteal bypass grafting procedures, compared with
the AAA group (50%), although this did not reach
statistical significance. Fifty percent of the patients in
the AAA group had bypass grafts to the tibial vessels
(Table III). There were no differences in the num-
ber of distal runoff vessels shown by means of
angiogram between the AAA and the ABF group
(Table IV).
Patency, limb salvage, and mortality. Life table
analysis comparing primary and primary revised
patency after IR in the AAA, ABF, and LEB groups
was revealed (Fig 1). Primary graft patency in the
AAA group at 3, 24, and 60 months was superior to
that in the LEB and ABF groups. At 3 months, the
primary patency rate in the AAA group was 100%,
whereas the primary patency rate in the ABF group
was 75% ± 7% (P < .001). Similarly, at 24 months,
the cumulative primary patency rate in the AAA
group was 92% ± 5%, compared with 57% ± 9% in
the ABF group (P < .008) and 72% ± 1% in the LEB
group (P < .008). These differences persisted to 60
months, with a primary patency rate of 92% ± 5% in
the AAA group, compared with 44% ± 11% in the
ABF group (P < .001) and 63% ± 2% in the LEB
group (P < .001; Fig 1, A). The 5-year cumulative
primary revised patency rate in the AAA group was
95% ± 5%. The 5-year cumulative primary revised
patency rate was 54% ± 11% in the ABF group (P <
.001, compared with the AAA group) and 71% ± 2%
in the LEB group (P < .001, compared with the
AAA group; Fig 1, B). The cumulative 5-year limb
salvage rate was significantly improved in the AAA
group (95% ± 5%), compared with the ABF group
(62% ± 14%; P < .01) and the LEB group (85% ± 1%;
P < .001).
The low primary and primary revised IR patency
rates in the ABF group could not be explained by
inferior ABF bypass graft patency, because the
cumulative 5-year primary patency rate was 88% ±
4% for the ABF bypass grafts. When the origination
of the IR was examined, 65% of the lower-extremity
bypass grafts originated off prosthetic material in the
ABF group, compared with 27% of those in the AAA
group (P < .002). In the AAA group, 10 patients
(33%) had aortic reconstructions that involved at
least one aortofemoral bypass graft. At 3 months,
there was a statistically significant difference in IR
primary patency in the ABF group among IRs orig-
inating from different sites: 100% from native artery
versus 72% from prosthetic graft (P < .002). This
difference did not persist to 24 or 60 months. When
5-year cumulative IR primary patency was compared
by origin, the AAA group had a significantly higher
primary patency rate (P < .001), whether the IR
originated off of native artery or prosthetic, than the
ABF group (Fig 2).
Native arterial diameter measurements. Native
inflow (CFA, PFA, SFA) and outflow (POP, AT, PT,
and PER) arterial diameters were evaluated by means
of arteriography in 17 patients. A significant differ-
ence in overall arterial diameter between the AAA
and ABF groups (P = .001) was revealed by means of
linear regression analysis (Fig 3). This overall differ-
ence in arterial diameter existed primarily because of
a significant increase (P = .001) in the inflow size
(CFA, SFA, and PFA) in the AAA group, compared
with that in the ABF group. These two smaller
cohorts were well matched for sex, demographics,
indication for operation, graft orientation, anasto-
motic site, and number of runoff vessels. Similar to
the comparison made between the two larger groups,
patients with a prior AAA repair in this cohort had a
significantly improved IR primary patency rate (82%
± 16%) at 4 years, compared with patients with a
prior ABF bypass graft (27% ± 13%, P < .005).
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Fig 4. Mean initial and final vein graft diameter (in milli-
meters) by means of duplex ultrasonography scanning in a
subset of grafts in patients with previous abdominal aortic
aneurysms (AAA) and aortobifemoral bypass grafting
(ABF) for aortoiliac occlusive disease. *P < .05.
Table IV. Number of distal runoff vessels in the
AAA and ABF groups
Number of 
runoff vessels AAA group N (%) ABF group N (%)
3 5 (17) 8 (24)
2 8 (27) 12 (35)
1 12 (40) 10 (29)
0 1 (3) 3 (9)
Not available 4 (13) 1 (3)
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Duplex measurement of vein graft diameters.
Variations over time in vein graft diameter were
measured by using serial duplex ultrasonography of
the 12 native vein bypass grafts. Serial ultrasound
scans (two per graft) were performed, with the ini-
tial surveillance ultrasound scanning occurring with-
in 3 months after graft insertion. The period from
the initial to the final follow-up ultrasound scanning
examinations ranged from 8 months to 3 years (P =
not significant, AAA vs ABF groups). When mean
vein graft diameter was determined, a progressive
increase in vein graft diameter occurred with time in
the AAA group, from 3.7 ± 0.5 mm to 4.5 ± 0.7 mm
(P < .05). No significant difference occurred in vein
graft diameter in the ABF group (initial, 3.8 ± 0.6
mm vs final, 3.4 ± 0.7 mm; Fig 4). Table V demon-
strates that each of the vein graft diameters increased
over time in the AAA group, compared with a
decrease over time in the ABF group.
DISCUSSION
In this study, infrainguinal vein bypass graft pri-
mary patency, primary revised patency, and limb sal-
vage rates were superior in patients with prior AAA
repairs, compared with patients who had undergone
prior ABF repairs for aortoiliac occlusive disease. In
addition, patients with prior ABF reconstructions
had significantly decreased patency and limb salvage
rates, compared with patients without prior aortic
reconstructions. Although more of the IRs in the
ABF group originated off a limb of prosthetic mate-
rial than those in the AAA group, we could not
demonstrate that graft origination contributed to
the poorer-than-expected patency rate results in the
ABF group. In fact, the primary patency rate of IRs
originating from both native artery and prosthetic
material was significantly decreased in the ABF
group, compared with the AAA group, regardless of
the IR origin in the latter group. This suggests that
other mechanisms, unrelated to graft origination,
may contribute to the decreased IR patency rates in
the ABF group. One can speculate that the presence
of significant CFA, SFA, and outflow atherosclerot-
ic disease may have contributed to this result.
In an attempt to provide other possible mecha-
nisms to explain the superior patency rates in IRs in
patients with prior AAA repairs, we examined native
arterial size and vein graft diameter in two subsets of
AAA and ABF patients undergoing IRs. Although
the numbers of IRs examined were small, a larger
arterial diameter on angiogram in the AAA group
was documented in the proximal lower-extremity
arteries (CFA, SFA, and PFA). In addition, an
increase in vein graft diameter over time occurred in
the AAA group, but not in the ABF group, suggest-
ing that changes in vein graft adaptation occurs in
patients with centrally located aneurysms, similar to
our initial observation in patients with popliteal
artery aneurysms.1 These data support the hypothe-
sis that aneurysm disease is a systemic process affect-
ing the vascular wall biology of veins and arteries in
patients with aortic and peripheral arterial
aneurysms. A number of other studies support this
hypothesis, because vein graft aneurysms have been
reported after distal lower-extremity4-6 and aorto-
coronary7-8 reconstructions. Although the exact
mechanism responsible for the greater-than-expect-
ed IR patency rates in the AAA group remains unde-
fined, graft origination, larger arterial diameter, and
increasing vein graft diameter may contribute.
One needs to consider the possibility that a type
II statistical error may have occurred when compar-
Table V. Vein graft diameters in AAA and ABF groups
Aortic surgery Initial diameter (mm) Final diameter (mm) Increase/decrease
AAA group
Patient 1 4.0 4.7 Increase
Patient 2 3.6 4.7 Increase
Patient 3 3.6 4.9 Increase
Patient 4 3.6 4.9 Increase
Patient 5 3.4 4.6 Increase
Patient 6 3.8 3.9 Increase
ABF group
Patient 1 3.8 3.4 Decrease
Patient 2 3.7 3.6 Decrease
Patient 3 4.0 3.6 Decrease
Patient 4 3.6 3.4 Decrease
Patient 5 3.6 3.2 Decrease
Patient 6 3.9 3.1 Decrease
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ing demographics, graft patency rates, and limb sal-
vage rates. Because the numbers in the present ret-
rospective analysis are small, any attempt to make a
demonstrable statement about the exact mechanism
by which alterations in graft patency occurred would
be overstated. Another possible type II error may
have occurred when we were trying to discover
whether graft origination (native vs prosthetic) con-
tributed to differences in IR patency rates. Because
most of the IR graft failures in the ABF group
occurred in the first 6 months, technical differences,
such as graft origination (native vs prosthetic), are
likely important. In addition, because of the small
numbers, the effect of having fewer patients with
diabetes mellitus in the AAA group on IR graft
patency could not be validly determined.
In a previous study, we documented that vein
grafts performed for popliteal artery aneurysms
increased in diameter with time.1 Altered remodeling
of vein grafts performed in patients with peripheral
arterial aneurysms lead to improved bypass grafting
patency rates. The development of aneurysmal dila-
tion of arterialized autogenous saphenous vein grafts,
primarily in patients with popliteal artery aneurysms,
has recently been studied by others. Loftus et al2 sug-
gested that 42% of patients undergoing lower-
extremity bypass grafting with autogenous vein for
popliteal artery aneurysms have an increase of more
than 1.5 cm in the graft diameter with time. This is
compared with only 2% in patients with chronic
lower-extremity ischemia with atherosclerotic dis-
ease. Szilagyi et al4 examined the incidence of true
aneurysm formation in vein grafts and observed
aneurysmal changes in 10 of 260 bypass grafts.
The present study is the first to report improved
patency rates in IRs in patients with previous AAA
repairs. In addition to this observation, it was also
noted that IRs in the ABF group had a much lower
patency rate than those in patients without prior 
aortic surgery. Although patients with aortoiliac
occlusive disease may have a larger burden of athero-
sclerosis and the distal arterial disease may be more
progressive, in this analysis, the members of the AAA
group were older and had more co-morbidities.
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